Status:
UNKNOWN
The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Coronary Artery Disease
In-stent Restenosis
Eligibility:
All Genders
30-85 years
Brief Summary
This is a cross-sectional and follow-up study. We analysis the relationship of sleep quality on coronary artery disease(CAD) and in stent restenosis(ISR). Further, we explore the mechanism of relation...
Detailed Description
Background: Coronary artery disease (CAD) is the leading cause of mortality in the world. The important treatment of CAD is Percutaneous coronary intervention(PCI). However, in-stent-restenosis(ISR) i...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Coronary artery disease
- PCI patients in the follow-up
- written informed consent
Exclusion
- Heart failure; renal failure; secondary hypertension;valvular heart disease ;Cancer;
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2020
Estimated Enrollment :
958 Patients enrolled
Trial Details
Trial ID
NCT03874481
Start Date
November 1 2018
End Date
October 31 2020
Last Update
March 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hongjian Wang
Beijing, Beijing Municipality, China, 100037